Pharmafit Provence
INTRASITE Gel hydrogel 10T/15g

Smith & Nephew SAS

INTRASITE Gel hydrogel 10T/15g

CIP / EAN code: 3401073985725

Product information from VIDAL.

Read the product information
Back to the catalogue

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Parapharmacie

CE INTRASITETM GEL APPLIPAKTM

CE INTRASITETM CONFORMABLE
hydrogel

Forms and presentations 

Hydrogel for local application: 
  • Dosing applicators of 15 g in boxes of 5 and of 10 sterile doses.
  • Compresses impregnated with 15 g of Intrasite gel in a box of 10 sterile sachets.

Product (box of)ACL 13Tariff LPPR*Code LPPR
Gel:
15 g (5)340107339581425,63 euros6317413
15 g (10)340107398572536,62 euros6317360
Compress:
10 cm × 20 cm (10)340107781319236,62 euros6317360
* Tariff LPPR = maximum public sale price.

Composition 

Purified water: 77,70 %.
Propylene glycol: 20 %.
Sodium carboxymethylcellulose: 2,30 %.

Properties 

Intrasite hydrates the dry necrotic plaque, drains and absorbs fibrin and exudate, and can be used at all stages of debridement until granulation tissue covers the entire wound bed.

Indications 

Debridement of dry necrotic and fibrinous wounds of all types.

Directions for use 

  • Intrasite Gel Applipak: after cleaning the wound with water or physiological saline, apply a layer of gel of at least 5 mm on the lesion and cover with a suitable secondary dressing.
    Does not adhere to the wound, easy to remove: dressing change is atraumatic.
    Renewal is done every 1 to 3 days.
  • Intrasite Conformable: after cleaning the wound, apply the dressing ensuring to cover the wound bed and the margins of the wound even if tunnelled. Cover with a suitable secondary dressing.

Precautions for use 

  • For external use only.
  • Avoid contact with the eyes.
  • Do not use on nipple fissures, during breastfeeding.
  • Do not use if the applicator is open or damaged.
  • Allergy to any of the components.

After opening: any unused gel must be discarded.

Do not use for more than one patient.

ADMINISTRATIVE INFORMATION 

LPPR rate:
Coverage is provided in sequential treatment for chronic wounds in the debridement phase.

CE marking-2797. Class II b.

SMITH & NEPHEW SAS
40-52, bd du Parc. 92200 Neuilly-sur-Seine
Reception:

Customer service:

Fax: 01 46 41 24 11
Website: http://www.smith-nephew.com/france

Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.